Biofrontera Inc (NASDAQ:BFRI)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 0.38. At the close of trading, the stock’s price was $1.00, to imply a decrease of -0.99% or -$0.01 in intraday trading. The BFRI share’s 52-week high remains $4.00, putting it -300.0% down since that peak but still an impressive 39.0% since price per share fell to its 52-week low of $0.61. The company has a valuation of $7.75M, with an average of 1.85 million shares in intraday trading volume over the past 10 days and average of 2.84 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Biofrontera Inc (BFRI), translating to a mean rating of 1.00. Of 2 analyst(s) looking at the stock, 0 analyst(s) give BFRI a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 2 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.07.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biofrontera Inc (NASDAQ:BFRI) trade information
After registering a -0.99% downside in the last session, Biofrontera Inc (BFRI) has traded red over the past five days. The 5-day price performance for the stock is 11.11%, and 13.28% over 30 days. With these gigs, the year-to-date price performance is -63.90%. Short interest in Biofrontera Inc (NASDAQ:BFRI) saw shorts transact 0.46 million shares and set a 0.08 days time to cover.
Biofrontera Inc (BFRI) estimates and forecasts
Looking at statistics comparing Biofrontera Inc share performance against respective industry, we note that the company has outperformed competitors. Biofrontera Inc (BFRI) shares are 1.01% up over the last 6 months, with its year-to-date growth rate higher than industry average at 81.39% against 17.50%. The rating firms project that company’s revenue will grow 15.38% compared to the previous financial year.
Revenue forecast for the current quarter as set by 2 analysts is 14.53M. Meanwhile, for the current quarter, a total of 2 analyst(s) estimate revenue growth to 11.5M.Earnings reports from the last fiscal year show that sales brought in 10.6M and 7.91M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 37.13% before jumping 45.35% in the following quarter.
BFRI Dividends
Biofrontera Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Biofrontera Inc (NASDAQ:BFRI)’s Major holders
Biofrontera Inc insiders hold 32.06% of total outstanding shares, with institutional holders owning 20.68% of the shares at 30.44% float percentage. In total, 20.68% institutions holds shares in the company.
